Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Short Report: Treatment"'
Autor:
Bally, L., Thabit, H., Ruan, Y., Mader, J. K., Kojzar, H., Dellweg, S., Benesch, C., Hartnell, S., Leelarathna, L., Wilinska, M. E., Evans, M. L., Arnolds, S., Pieber, T. R., Hovorka, R.
Publikováno v:
Diabetic Medicine
Aim To compare bolus insulin delivery patterns during closed‐loop home studies in adults with suboptimally [HbA1c 58–86 mmol/mol (7.5%–10%)] and well‐controlled [58 mmol/mol (< 7.5%)] Type 1 diabetes. Methods Retrospective analysis of daytime
Publikováno v:
Diabetic Medicine
Aim This post hoc analysis explored whether mealtime fast‐acting insulin aspart treatment provided an advantage in postprandial plasma glucose (PPG) control vs. insulin aspart in people with Type 2 diabetes receiving high doses of bolus insulin. Me
Autor:
Angie S Page, Duncan Procter, Simon J Sebire, Clare England, Emma Ranger, Byron Tibbitts, Ashley R Cooper, Aidan Searle
Publikováno v:
Cooper, A, Tibbitts, B, England, C, Procter, D, Searle, A, Sebire, S, Ranger, E & Page, A 2018, ' The potential of electric bicycles to improve the health of people with type 2 diabetes : a feasibility study ', Diabetic Medicine . https://doi.org/10.1111/dme.13664
Diabetic Medicine
Diabetic Medicine
Aim To explore in a feasibility study whether ‘e‐cycling’ was acceptable to, and could potentially improve the health of, people with Type 2 diabetes. Methods Twenty people with Type 2 diabetes were recruited and provided with an electric bicyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51e7f27aa28b14bc254f56e7144c63f
https://research-information.bris.ac.uk/en/publications/9484f3bb-4552-4939-8eec-aa002c450e17
https://research-information.bris.ac.uk/en/publications/9484f3bb-4552-4939-8eec-aa002c450e17
Autor:
Adlija Causevic, Tamer Bego, Ewan R. Pearson, Zelija Velija-Asimi, Sabina Semiz, Tanja Dujic, Maja Malenica
Publikováno v:
Diabetic Medicine
Aims Metformin is the most widely used oral anti‐diabetes agent and has considerable benefits over other therapies, yet 20–30% of people develop gastrointestinal side effects, and 5% are unable to tolerate metformin due to the severity of these s
Publikováno v:
Diabetic Medicine
Aims To evaluate whether fasting plasma glucose values measured early during insulin therapy can identify patients with Type 2 diabetes who may not achieve adequate glycaemic control after 6 months and will require additional treatment. Methods Patie